tiprankstipranks
Moderna (MRNA)
NASDAQ:MRNA

Moderna (MRNA) Technical Analysis

15,159 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
6Neutral
5Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Moderna’s (MRNA) Moving Averages Convergence Divergence (MACD) indicator is 10.49, suggesting Moderna is a Sell.
Moderna’s (MRNA) 20-Day exponential moving average is 139.41, while Moderna’s (MRNA) share price is $142.55, making it a Buy.
Moderna’s (MRNA) 50-Day exponential moving average is 124.44, while Moderna’s (MRNA) share price is $142.55, making it a Buy.

Moderna (MRNA) Pivot Points

Jun 03, 2024, 01:56 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
136.47
140.00
145.74
149.27
155.01
158.54
164.28
Fibonacci
140.00
143.54
145.73
149.27
152.81
155.00
158.54
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Moderna (MRNA) Moving Averages

Jun 03, 2024, 01:56 AM
Period
Simple
Exponential
MA5
152.35Sell
149.19Sell
MA10
150.67Sell
147.39Sell
MA20
137.63Buy
139.41Buy
MA50
119.15Buy
124.44Buy
MA100
109.05Buy
114.19Buy
MA200
101.01Buy
109.01Buy
Moderna’s (MRNA) 10-Day exponential moving average is 147.39, while Moderna’s (MRNA) share price is $142.55, making it a Sell.
Moderna’s (MRNA) 100-Day exponential moving average is 114.19, while Moderna’s (MRNA) share price is $142.55, making it a Buy.
Moderna’s (MRNA) stock price is $142.55 and Moderna’s (MRNA) 50-day simple moving average is 119.15, creating a Buy signal.
Moderna’s (MRNA) stock price is $142.55 and Moderna’s (MRNA) 100-day simple moving average is 109.05, creating a Buy signal.
Moderna’s (MRNA) stock price is $142.55 and Moderna’s (MRNA) 200-day simple moving average is 101.01, creating a Buy signal.

Moderna (MRNA) Technical Indicators

Jun 03, 2024, 01:56 AM
Name
Value
Implied Action
RSI (14)
56.21
Neutral
STOCH (9,6)
42.85
Neutral
STOCHRSI (14)
56.15
Neutral
MACD (12,26)
10.49
Sell
ADX (14)
36.61
Neutral
Williams %R
-54.28
Buy
CCI (14)
51.71
Neutral
ATR (14)
8.99
-
Ultimate Oscillator
59.64
Neutral
ROC
21.52
Buy
Moderna’s (MRNA) Relative Strength Index (RSI) is 56.21, creating a Neutral signal.
Moderna’s (MRNA) Trend Strength Indicator (ADX) is 36.61, creating a Neutral signal.
Moderna’s (MRNA) Commodity Channel Index (CCI) is 51.71, creating a Neutral signal.
Moderna’s (MRNA) Price Rate of Change (ROC) is 21.52, creating a Buy signal.

FAQ

Is MRNA a Buy, Hold, or Sell?
Based on MRNA’s technical indicators, MRNA is a Buy.
    What is MRNA’s RSI (14)?
    MRNA’s RSI (14) is 56.21, which suggests MRNA is a Neutral.
      What is MRNA’s MACD?
      MRNA’s MACD is 10.49, which suggests MRNA is a Sell.
        What is MRNA’s 5-day moving average?
        MRNA’s 5-day moving average is 152.35, which suggests MRNA is a Sell.
          What is MRNA’s 20-day moving average?
          MRNA 20-day moving average is 137.63, which suggests MRNA is a Buy.
            What is MRNA’s 50-day moving average?
            MRNA’s 50-day moving average is 119.15, which suggests MRNA is a Buy.
              What is MRNA’s 200-day moving average?
              MRNA’s 200-day moving average is 101.01, which suggests MRNA is a Buy.
                What is MRNA’s Williams % R (14)?
                MRNA’s Williams % R (14) is -54.28, which suggests MRNA is a Buy.
                  What is MRNA’s CCI (14)?
                  MRNA’s CCI (14) is 51.71, which suggests MRNA is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis